CBS 2019
CBSMD教育中心
中 文

动脉粥样硬化性心血管疾病

Abstract

Recommended Article

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes The Year in Cardiovascular Medicine 2020: Coronary Prevention: Looking back on the Year in Cardiovascular Medicine for 2020 in the field of coronary prevention is Professor Ramon Estruch, Dr Luis Ruilope, and Professor Francesco Cosentino. Mark Nicholls meets them Association Between Depressive Symptoms and Incident Cardiovascular Diseases Value of Coronary Artery Calcium Scanning in Association With the Net Benefit of Aspirin in Primary Prevention of Atherosclerotic Cardiovascular Disease Effect of the PCSK9 Inhibitor Evolocumab on Total Cardiovascular Events in Patients With Cardiovascular DiseaseA Prespecified Analysis From the FOURIER Trial Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy The sinus venosus contributes to coronary vasculature through VEGFC-stimulated angiogenesis High-Risk Coronary Plaque Regression After Intensive Lifestyle Intervention in Nonbstructive Coronary Disease: A Randomized Study

Recommandation StatementMay 4, 2020

JOURNAL:Circulation. Article Link

Cardiovascular Considerations in Caring for Pregnant Patients: A Scientific Statement From the American Heart Association

LS Mehta , CA Warnes, and On behalf of the American Heart Association Council on Clinical Cardiology; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; and Stroke Council Keywords: cardiovascular disease; pregnancy

Full Text PDF